New rule for Cough syrup export to kick start from June 2023

The Cough syrup exporters will have to undertake testing of their products at specified government laboratories from June 1

New-Delhi: The Cough syrup exporters will have to undertake testing of their products at specified government laboratories from June 1 before getting any permission for the outbound shipments.

“The export of cough syrup shall be permitted to be exported subject to export samples being tested and production of a certificate of analysis issued by any of the laboratories, with effect from June 1, 2023,” the Directorate General of Foreign Trade (DGFT) said in a notification on Monday.

The specified central government labs include Indian Pharmacopoeia Commission, regional drug testing lab (RDTL – Chandigarh), central drugs lab (CDL – Kolkata), central drug testing lab (CDTL – Chennai Hyderabad, Mumbai), RDTL (Guwahati)] and the NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited drug testing labs of state governments.

The WHO said last year the syrups, made by Indian manufacturer Maiden Pharmaceuticals Ltd, contained lethal toxins ethylene glycol (EG) and diethylene glycol (DEG) used in car brake fluid. These ingredients can be used by unscrupulous actors as a substitute for propylene glycol (PG), which is a key base of syrup medicines.

In the year 2022-23, India exported cough syrups worth USD 17.6 billion against USD 17 billion in 2021-22.

Also Read: WHO Cautions Against Consuming Two India-Made Cough Syrups

 
Kalinga TV is now on WhatsApp. Join today to get latest Updates
 
Leave A Reply

Your email address will not be published.